DAIC

JUNE 11, 2024

The center will explore the potential of these devices and treatments as the standard of care in managing tricuspid and mitral valve disorders. According to Kodali, the Center’s wealth of expertise and experience will help drive these advances.

Tricuspid 111

Tricuspid Bicuspid/Mitral Heart Valves Innovation 111

DAIC

JANUARY 31, 2024

TEE is also a valuable tool for minimally invasive heart surgeries and procedures, transforming the treatment of damaged heart valves and congenital heart defects [2]. As a pioneer and leading innovator in cardiac ultrasound, our 3D ultrasound technology plays a critical role in many cardiac procedures.

Ultrasound 111

Ultrasound Technology Innovation Heart Valves 111

DAIC

APRIL 23, 2024

milla1cf Tue, 04/23/2024 - 15:53 April 23, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. This next-generation surgical aortic tissue valve is designed to facilitate ease of use at implant and lifetime patient management.

Aortic valve 111

Aortic valve Aortic Innovation Cardiothoracic 111

DAIC

JUNE 13, 2024

Getty Images milla1cf Thu, 06/13/2024 - 20:38 June 13, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. 3 Based on internal test report D00997823, Avalus Ultra Full Valve Stiffness Design Verification Report.

Aortic valve 109

Aortic valve Aortic Innovation Cardiothoracic 109

DAIC

JANUARY 24, 2024

Barr’s death at 39 from sudden cardiac arrest was caused by mitral valve prolapse—a heart valve defect that can affect the heart’s ability to pump blood. Makkar: Also, patients have earlier access to the most innovative treatments because we are often leading clinical trials and using new devices and novel approaches.

Bicuspid/Mitral 105

Bicuspid/Mitral Research Heart Valves Cardiac Arrest 105

DAIC

MAY 1, 2024

The Society for Cardiovascular Angiography & Interventions (SCAI) kicks off its SCAI Scientific Sessions 2024 this week, May 2-4 in Long Beach, CA, bringing together more than 1,800 clinicians, scientists, researchers, and innovators in the field of interventional cardiology and endovascular medicine.

Interventional Cardiology 105

Interventional Cardiology Aortic valve TAVR Peripheral Arterial Disease 105

DAIC

MARCH 8, 2024

The teams will combine innovative engineering designs, antithrombotic slippery hydrophilic (SLIC) coatings, wireless power transfer systems, magnetically levitated driving systems and preclinical device testing to achieve their goal. He is an expert in prosthetic heart valves and cardiovascular biomechanics, biomaterials and devices.

Blood Clot 98

Blood Clot Heart Failure Quality of Life Innovation 98

Journal of Cardiothoracic Surgery

AUGUST 29, 2024

The patient underwent a successful TAVI procedure using the XL-Myval 32 mm transcatheter heart valve (THV) via an anterior right mini-thoracotomy with a direct aortic approach. The patient recovered well post-operatively with good hemodynamic resolution.

Aortic 52

Aortic Aortic valve Heart Valves Innovation 52

DAIC

JUNE 12, 2024

Additionally, the company also offers the first fully automated 3D quantification of mitral regurgitation (MR) volumes* designed to provide reproducible, efficient analysis helps clinicians make better-informed decisions for patients with heart valve disease. “As

Ultrasound 105

Ultrasound Cardio Oncology Technology Congenital Heart Disease 105

Frontiers in Cardiovascular Medicine

JULY 21, 2024

These included innovation characteristics, external and internal settings, and individual dynamics. IntroductionEnhanced Recovery After Surgery (ERAS) protocols represent a paradigm shift in perioperative care, aim to optimize patient outcomes and accelerate recovery.

Heart Valves 59

Heart Valves Academic Nursing Innovation 59

ADN Center of Excellence

JANUARY 14, 2024

Ibrahim Halil Kurt, President of Heart Valve Disease in the Turkish Society of Cardiology, the event showcased the latest techniques and innovations in this life-saving procedure. Under the guidance of Prof.

Interventional Cardiology 59

Interventional Cardiology Education Heart Valves Aortic valve 59

ADN Center of Excellence

DECEMBER 14, 2023

At ADN CoE, we are dedicated to empowering medical professionals through a diverse range of fellowship programs meticulously crafted to nurture expertise and innovation. We offer a comprehensive array of courses spanning from advanced structural heart interventions to Advanced Urology, Bariatric surgery, Cardiovascular Surgery, and beyond.

Innovation 52

Innovation Heart Valves Aortic valve Cardiovascular Surgery 52

ADN Center of Excellence

JANUARY 14, 2024

Ibrahim Halil Kurt, President of Heart Valve Disease in the Turkish Society of Cardiology, the event showcased the latest techniques and innovations in this life-saving procedure. Under the guidance of Prof.

Research 52

Research Education Heart Valves Aortic valve 52

DAIC

JUNE 11, 2024

The center will explore the potential of these devices and treatments as the standard of care in managing tricuspid and mitral valve disorders. According to Kodali, the Center’s wealth of expertise and experience will help drive these advances.

Tricuspid 52

Tricuspid Bicuspid/Mitral Heart Valves Innovation 52

Wellnest

JANUARY 24, 2024

In a remarkable leap forward for pediatric cardiac care, a groundbreaking partial heart transplant procedure has emerged as a beacon of hope for infants facing severe congenital heart conditions. This unique case presented an opportunity to utilize the heart after cardiac death through standard surgical techniques.

Heart Transplant 52

Heart Transplant Transplant Pediatrics Congenital 52

DAIC

JANUARY 16, 2024

His industry roles have included serving as Chief Medical Officer for HLT Medical, a transcatheter heart valve company, as Chief of Cardiology with Optum/United Health subsidiary SCA Health, and as Medical Director for clinical research organization Medpace.

Bicuspid/Mitral 59

Bicuspid/Mitral Heart Failure Catheterization Laboratory Innovation 59

ADN Center of Excellence

DECEMBER 14, 2023

At ADN CoE, we are dedicated to empowering medical professionals through a diverse range of fellowship programs meticulously crafted to nurture expertise and innovation. We offer a comprehensive array of courses spanning from advanced structural heart interventions to Advanced Urology, Bariatric surgery, Cardiovascular Surgery, and beyond.

Innovation 40

Innovation Heart Valves Aortic valve Cardiovascular Surgery 40

ADN Center of Excellence

JANUARY 14, 2024

Under the expert guidance of our seasoned instructors and anatomy specialist, this session offered a wealth of practical insights, allowing attendees to delve into the intricacies of heart valve anatomy.

Bicuspid/Mitral 59

Bicuspid/Mitral Anatomy Education Heart Valves 59

Frontiers in Cardiovascular Medicine

JANUARY 7, 2024

Background Percutaneous pulmonary valve implantation (PPVI) has emerged as a less invasive alternative for treating severe pulmonary regurgitation after tetralogy of Fallot (TOF) repair in patients with a native right ventricular outflow tract (RVOT).

Pulmonary 49

Pulmonary Heart Valves Innovation Technology 49

ADN Center of Excellence

JANUARY 14, 2024

Under the expert guidance of our seasoned instructors and anatomy specialist, this session offered a wealth of practical insights, allowing attendees to delve into the intricacies of heart valve anatomy.

Bicuspid/Mitral 52

Bicuspid/Mitral Anatomy Education Heart Valves 52

DAIC

DECEMBER 26, 2023

About Aortic Stenosis Aortic valve stenosis - or aortic stenosis - is a type of heart valve disease (valvular heart disease). The valve between the lower left heart chamber and the body's main artery (aorta) is narrowed and doesn't open fully.

Stenosis 59

Stenosis Technology Aortic Aortic valve 59

DAIC

APRIL 2, 2024

Food and Drug Administration (FDA) approval of its TriClip, a first-of-its-kind device to repair leaky tricuspid heart valve, for which more than 1.6 Abbott has announced U.S million people in the U.S. are estimated to be affected. The device has already been used to treat more than 10,000 people with TR. 10.21037/cdt.2019.09.11.

Tricuspid 105

Tricuspid Heart Valves Quality of Life Open-Heart Surgery 105

DAIC

DECEMBER 22, 2023

Tricuspid regurgitation (TR) is a common and serious disease for which open heart surgery and symptomatic pharmacologic treatment are the current standard treatment options. Owing to high mortality risk, access to open heart surgery is severely restricted and is not considered an option for most patients with TR.

Tricuspid 59

Tricuspid Pacemaker Heart Valves Open-Heart Surgery 59

DAIC

MARCH 15, 2024

Widely recognized for pioneering innovative concepts and techniques in TAVR, Tang has set contemporary standards in the field. His impressive international academic collaborations include the establishment of multiple global registries and the training of heart teams in structural heart imaging and procedures worldwide.

TAVR 105

TAVR Academic Education Cardiovascular Surgery 105

Cardiology Update

JANUARY 7, 2024

The conference features live demonstrations, training workshops, simulations, clinical cases, late-breaking trials, innovations, and selected scientific abstracts. The scope of the meeting extends across the vast field of interventional cardiology, with specific emphasis on coronary, valve, and structural interventions.

Interventional Cardiology 64

Interventional Cardiology Innovation Heart Disease Physiology 64

DAIC

MARCH 15, 2024

Widely recognized for pioneering innovative concepts and techniques in TAVR, Tang has set contemporary standards in the field. His impressive international academic collaborations include the establishment of multiple global registries and the training of heart teams in structural heart imaging and procedures worldwide.

TAVR 52

TAVR Academic Education Cardiovascular Surgery 52